KESIMPTA® from Novartis
For Relapsing Multiple Sclerosis (RMS) • Branded DTC Campaign
DTC DSE Website
Owned copy and information architecture for kesimpta.com through platform migration, label update, and phased messaging shifts. Balanced regulatory rigor with improved user experience and delivering clear, accessible storytelling.
Decision Guide
Directed messaging architecture and mobile-first structure for a doctor discussion guide—translating high-level client objectives into a streamlined, interactive tool designed to support meaningful treatment conversations.
Social Campaign
Developed cross-platform social copy—tailoring tone by channel to bring the campaign’s patient-first narrative to life and drive meaningful engagement.
New Campaign Exploration
Developed a rhythm-driven campaign platform to replace existing positioning with a more dynamic, culturally resonant direction. Advanced to final-round consideration across agency and client leadership.
